85 related articles for article (PubMed ID: 29298647)
1. Saccharolactone: The History, the Myth, and the Practice.
Argikar UA
Curr Drug Metab; 2018; 19(4):304-309. PubMed ID: 29298647
[TBL] [Abstract][Full Text] [Related]
2. Effect of the beta-glucuronidase inhibitor saccharolactone on glucuronidation by human tissue microsomes and recombinant UDP-glucuronosyltransferases.
Oleson L; Court MH
J Pharm Pharmacol; 2008 Sep; 60(9):1175-82. PubMed ID: 18718121
[TBL] [Abstract][Full Text] [Related]
3. Glucuronidation of diflunisal by rat liver microsomes. Effect of microsomal beta-glucuronidase activity.
Brunelle FM; Verbeeck RK
Biochem Pharmacol; 1993 Dec; 46(11):1953-8. PubMed ID: 8267644
[TBL] [Abstract][Full Text] [Related]
4. Effect of Saccharolactone on CYP-mediated Metabolism of Xenobiotics.
Behera D; Jain P; Kurawattimath V; Gowda N
Drug Metab Bioanal Lett; 2023; 16(2):121-132. PubMed ID: 37612873
[TBL] [Abstract][Full Text] [Related]
5. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
[TBL] [Abstract][Full Text] [Related]
6. In vitro studies in microsomes from rat and human liver, kidney, and intestine suggest that perfluorooctanoic acid is not a substrate for microsomal UDP-glucuronosyltransferases.
Kemper RA; Nabb DL
Drug Chem Toxicol; 2005; 28(3):281-7. PubMed ID: 16051554
[TBL] [Abstract][Full Text] [Related]
7. Glucuronidation of curcuminoids by human microsomal and recombinant UDP-glucuronosyltransferases.
Hoehle SI; Pfeiffer E; Metzler M
Mol Nutr Food Res; 2007 Aug; 51(8):932-8. PubMed ID: 17628876
[TBL] [Abstract][Full Text] [Related]
8. Characterization of 1'-hydroxymidazolam glucuronidation in human liver microsomes.
Zhu B; Bush D; Doss GA; Vincent S; Franklin RB; Xu S
Drug Metab Dispos; 2008 Feb; 36(2):331-8. PubMed ID: 17998299
[TBL] [Abstract][Full Text] [Related]
9. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
[TBL] [Abstract][Full Text] [Related]
10. In vitro glucuronidation kinetics of deoxynivalenol by human and animal microsomes and recombinant human UGT enzymes.
Maul R; Warth B; Schebb NH; Krska R; Koch M; Sulyok M
Arch Toxicol; 2015 Jun; 89(6):949-60. PubMed ID: 24927789
[TBL] [Abstract][Full Text] [Related]
11. UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for etoposide glucuronidation in human liver and intestinal microsomes: structural characterization of phenolic and alcoholic glucuronides of etoposide and estimation of enzyme kinetics.
Wen Z; Tallman MN; Ali SY; Smith PC
Drug Metab Dispos; 2007 Mar; 35(3):371-80. PubMed ID: 17151191
[TBL] [Abstract][Full Text] [Related]
12. Characterization of hepatic and intestinal glucuronidation of magnolol: application of the relative activity factor approach to decipher the contributions of multiple UDP-glucuronosyltransferase isoforms.
Zhu L; Ge G; Zhang H; Liu H; He G; Liang S; Zhang Y; Fang Z; Dong P; Finel M; Yang L
Drug Metab Dispos; 2012 Mar; 40(3):529-38. PubMed ID: 22180045
[TBL] [Abstract][Full Text] [Related]
13. Identification of human UDP-glucuronosyltransferases involved in N-carbamoyl glucuronidation of lorcaserin.
Sadeque AJ; Usmani KA; Palamar S; Cerny MA; Chen WG
Drug Metab Dispos; 2012 Apr; 40(4):772-8. PubMed ID: 22259019
[TBL] [Abstract][Full Text] [Related]
14. Morphine glucuronidation and glucosidation represent complementary metabolic pathways that are both catalyzed by UDP-glucuronosyltransferase 2B7: kinetic, inhibition, and molecular modeling studies.
Chau N; Elliot DJ; Lewis BC; Burns K; Johnston MR; Mackenzie PI; Miners JO
J Pharmacol Exp Ther; 2014 Apr; 349(1):126-37. PubMed ID: 24459244
[TBL] [Abstract][Full Text] [Related]
15. Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.
Shiraga T; Yajima K; Suzuki K; Suzuki K; Hashimoto T; Iwatsubo T; Miyashita A; Usui T
Drug Metab Dispos; 2012 Feb; 40(2):276-82. PubMed ID: 22031623
[TBL] [Abstract][Full Text] [Related]
16. Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism.
Picard N; Ratanasavanh D; Prémaud A; Le Meur Y; Marquet P
Drug Metab Dispos; 2005 Jan; 33(1):139-46. PubMed ID: 15470161
[TBL] [Abstract][Full Text] [Related]
17. Targeted screen for human UDP-glucuronosyltransferases inhibitors and the evaluation of potential drug-drug interactions with zafirlukast.
Oda S; Fujiwara R; Kutsuno Y; Fukami T; Itoh T; Yokoi T; Nakajima M
Drug Metab Dispos; 2015 Jun; 43(6):812-8. PubMed ID: 25834030
[TBL] [Abstract][Full Text] [Related]
18. N-Glucuronidation of the antiepileptic drug retigabine: results from studies with human volunteers, heterologously expressed human UGTs, human liver, kidney, and liver microsomal membranes of Crigler-Najjar type II.
Borlak J; Gasparic A; Locher M; Schupke H; Hermann R
Metabolism; 2006 Jun; 55(6):711-21. PubMed ID: 16713428
[TBL] [Abstract][Full Text] [Related]
19. The glucuronidation of Delta4-3-Keto C19- and C21-hydroxysteroids by human liver microsomal and recombinant UDP-glucuronosyltransferases (UGTs): 6alpha- and 21-hydroxyprogesterone are selective substrates for UGT2B7.
Bowalgaha K; Elliot DJ; Mackenzie PI; Knights KM; Miners JO
Drug Metab Dispos; 2007 Mar; 35(3):363-70. PubMed ID: 17151189
[TBL] [Abstract][Full Text] [Related]
20. Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitors.
Walsky RL; Bauman JN; Bourcier K; Giddens G; Lapham K; Negahban A; Ryder TF; Obach RS; Hyland R; Goosen TC
Drug Metab Dispos; 2012 May; 40(5):1051-65. PubMed ID: 22357286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
